127 related articles for article (PubMed ID: 2577866)
1. Identification of a transforming activity suppressing sequence in the c-raf oncogene.
Ishikawa F; Sakai R; Ochiai M; Takaku F; Sugimura T; Nagao M
Oncogene; 1988 Dec; 3(6):653-8. PubMed ID: 2577866
[TBL] [Abstract][Full Text] [Related]
2. Identification by a random linker insertion method of a region which suppresses the transforming activity of the raf oncogene.
Ishikawa F; Sakai R; Ochiai M; Sugimura T; Nagao M
Nucleic Acids Symp Ser; 1988; (19):39-42. PubMed ID: 2852353
[TBL] [Abstract][Full Text] [Related]
3. A mechanism of c-raf-1 activation: fusion of the lipocortin II amino-terminal sequence with the c-raf-1 kinase domain.
Mitsunobu F; Fukui M; Oda T; Yamamoto T; Toyoshima K
Oncogene; 1989 Apr; 4(4):437-42. PubMed ID: 2524024
[TBL] [Abstract][Full Text] [Related]
4. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1.
Bosch E; Cherwinski H; Peterson D; McMahon M
Oncogene; 1997 Aug; 15(9):1021-33. PubMed ID: 9285556
[TBL] [Abstract][Full Text] [Related]
5. Raf-1 kinase and ERK2 uncoupled from mitogenic signals in rat fibroblasts.
Kortenjann M; Shaw PE
Oncogene; 1995 Nov; 11(10):2105-12. PubMed ID: 7478530
[TBL] [Abstract][Full Text] [Related]
6. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
[TBL] [Abstract][Full Text] [Related]
7. [Activated c-raf-1 gene from human stomach cancer].
Shimizu K; Nakatsu Y; Oh-uchida M; Nomoto S; Sekiguchi M
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2140-6. PubMed ID: 3300556
[TBL] [Abstract][Full Text] [Related]
8. Genomic organization and nucleotide sequence of the coding region of the chicken c-Rmil(B-raf-1) proto-oncogene.
Calogeraki I; Barnier JV; Eychene A; Felder MP; Calothy G; Marx M
Biochem Biophys Res Commun; 1993 Jun; 193(3):1324-31. PubMed ID: 8323553
[TBL] [Abstract][Full Text] [Related]
9. Transforming activity of the RL-akt gene, a c-akt gene activated by long terminal repeat insertion in murine leukemia RL(male symbol)1 cells.
Tanino M; Matsuo M; Uenaka A; Tsukuda K; Ouchida M; Nakayama E; Shimizu K
Mol Carcinog; 1999 Dec; 26(4):286-97. PubMed ID: 10569805
[TBL] [Abstract][Full Text] [Related]
10. Quail neuroretina c-Rmil(B-raf) proto-oncogene cDNAs encode two proteins of 93.5 and 95 kDa resulting from alternative splicing.
Eychène A; Barnier JV; Dézélée P; Marx M; Laugier D; Calogeraki I; Calothy G
Oncogene; 1992 Jul; 7(7):1315-23. PubMed ID: 1620546
[TBL] [Abstract][Full Text] [Related]
11. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
12. Activation of rat and human c-raf(-1) by rearrangement.
Nagao M; Ishikawa F; Tahira T; Ochiai M; Sugimura T
Princess Takamatsu Symp; 1986; 17():75-84. PubMed ID: 3332022
[TBL] [Abstract][Full Text] [Related]
13. PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase.
Cacace AM; Ueffing M; Philipp A; Han EK; Kolch W; Weinstein IB
Oncogene; 1996 Dec; 13(12):2517-26. PubMed ID: 9000126
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator.
Okazaki M; Kishida S; Hinoi T; Hasegawa T; Tamada M; Kataoka T; Kikuchi A
Oncogene; 1997 Feb; 14(5):515-21. PubMed ID: 9053849
[TBL] [Abstract][Full Text] [Related]
15. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
16. Correlation of constitutive activation of raf-1 with morphological transformation and abrogation of tyrosine phosphorylation of distinct sets of proteins in human squamous carcinoma cells.
Patel BK; Ray S; Whiteside TL; Kasid U
Mol Carcinog; 1997 Jan; 18(1):1-6. PubMed ID: 9022807
[TBL] [Abstract][Full Text] [Related]
17. Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA binding.
Fukasawa K; Zhou R; Matten WT; Armstrong AJ; Daar I; Oskarsson M; Sathyanarayana BK; Maclvor L; Wood TG; Vande Woude GF
Oncogene; 1995 Oct; 11(8):1447-57. PubMed ID: 7478569
[TBL] [Abstract][Full Text] [Related]
18. Regulation of A-raf expression.
Lee JE; Beck TW; Wojnowski L; Rapp UR
Oncogene; 1996 Apr; 12(8):1669-77. PubMed ID: 8622887
[TBL] [Abstract][Full Text] [Related]
19. The complete primary structure of the rat A-raf cDNA coding region: conservation of the putative regulatory regions present in rat c-raf.
Ishikawa F; Takaku F; Nagao M; Sugimura T
Oncogene Res; 1987 Aug; 1(3):243-53. PubMed ID: 3449797
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic activation of murine mos protein kinase by DNA rearrangement of its N-terminal coding region.
Ohuchi T; Kurita Y; Sasai H; Miyoshi J; Nomura T; Toyoshima K
Oncogene; 1992 Feb; 7(2):331-8. PubMed ID: 1532243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
